Provided by Tiger Trade Technology Pte. Ltd.

Zimmer Biomet

93.49
+1.051.14%
Post-market: 93.750.2600+0.28%19:38 EDT
Volume:1.88M
Turnover:174.47M
Market Cap:17.86B
PE:22.69
High:93.64
Open:92.95
Low:91.74
Close:92.44
52wk High:106.88
52wk Low:79.12
Shares:191.00M
Float Shares:190.00M
Volume Ratio:1.02
T/O Rate:0.99%
Dividend:0.96
Dividend Rate:1.03%
EPS(TTM):4.12
EPS(LYR):3.55
ROE:6.41%
ROA:3.88%
PB:1.41
PE(LYR):26.34

Loading ...

Zimmer Biomet Holdings Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Aug 20

Zimmer Biomet Holdings Inc. Stock Underperforms Monday When Compared to Competitors

Dow Jones
·
Aug 18

Zimmer Biomet Holdings Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Aug 14

Will Zimmer Biomet’s Upgraded 2026 Guidance and Buyback Shift Zimmer Biomet Holdings’ (ZBH) Narrative

Simply Wall St.
·
Aug 13

Analysts’ Opinions Are Mixed on These Healthcare Stocks: CG Oncology, Inc. (CGON) and Zimmer Biomet Holdings (ZBH)

TIPRANKS
·
Aug 13

Bank of America Securities Remains a Hold on Zimmer Biomet Holdings (ZBH)

TIPRANKS
·
Aug 11

Zimmer Biomet Raises Outlook Amid Transition Year

TIPRANKS
·
Aug 11

Zimmer Biomet Holdings Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Aug 11

Zimmer Biomet Holdings Price Target Raised to $100.00/Share from $83.00 by Canaccord Genuity

Dow Jones
·
Aug 10

Zimmer Biomet price target raised to $106 from $92 at Truist

TIPRANKS
·
Aug 07

Zimmer Biomet Holdings is Maintained at Hold by Truist Securities

Dow Jones
·
Aug 07

Treace Medical Q2 Revenue Tops Estimates on Higher Surgeon Adoption; Ups Outlook

Reuters
·
Aug 07

Truist Adjusts Price Target on Zimmer Biomet to $106 From $92, Maintains Hold Rating

MT Newswires Live
·
Aug 07

Zimmer Biomet price target raised to $93 from $91 at Bernstein

TIPRANKS
·
Aug 06

Enovis Slightly Beats Q2 Sales Estimates, Reaffirms 2026 Guidance

Reuters
·
Aug 06

Zimmer Biomet Holdings Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Aug 06

Novanta Beats Q2 Revenue Estimates on Organic Growth, Raises 2026 Guidance

Reuters
·
Aug 06

Envista Q2 Sales Rise on Segments Growth

Reuters
·
Aug 06

Solventum Q2 Sales, Adjusted EPS Beat Estimates; FY Outlook Lifted

Reuters
·
Aug 06

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Geron (GERN), Zimmer Biomet Holdings (ZBH) and Recursion Pharmaceuticals (RXRX)

TIPRANKS
·
Aug 06